CNBX PHARMACEUTICALS INC. Deferred Tax Assets, Operating Loss Carryforwards
CNBX PHARMACEUTICALS INC. (CNBX) had Deferred Tax Assets, Operating Loss Carryforwards of $3.54 million as of 2025-08-31, per its 10-K filed 2025-12-01.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-12-01
- 2025-08-31: Deferred Tax Assets, Operating Loss Carryforwards $3.54M.
- 2024-08-31: Deferred Tax Assets, Operating Loss Carryforwards $3.47M.
- 2023-08-31: Deferred Tax Assets, Operating Loss Carryforwards $3.34M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $5.98M.
- 2022-08-31: Deferred Tax Assets, Operating Loss Carryforwards $5.38M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-08-31 | $3.54M 10-K · filed 2025-12-01 | |
| 2024-08-31 | $3.47M 10-K · filed 2025-12-01 | |
| 2023-08-31 | $3.34M 10-K · filed 2024-11-29 | $5.98M 10-K · filed 2023-11-30 |
| 2022-08-31 | $5.38M 10-K · filed 2023-11-30 | |
| 2021-08-31 | $4.33M 10-K · filed 2022-11-30 | |
| 2020-08-31 | $3.62M 10-K · filed 2021-11-29 | |
| 2019-08-31 | $1.99M 10-K · filed 2020-11-04 | $1.63M 10-K · filed 2019-11-29 |
| 2018-08-31 | $2.23M 10-K · filed 2019-11-29 | |
| 2017-08-31 | $1.11M 10-K · filed 2018-11-29 | |
| 2016-08-31 | $516.59K 10-K · filed 2017-12-08 | |
| 2015-08-31 | $425.19K 10-K · filed 2016-12-13 | $434.68K 10-K · filed 2016-01-07 |
| 2014-08-31 | $250.84K 10-K · filed 2016-01-07 | |
| 2013-08-31 | $163.70K 10-K/A · filed 2015-10-23 | |
| 2012-08-31 | $144.00K 10-K · filed 2013-11-29 | |
| 2011-08-31 | $143.50K 10-K · filed 2012-11-30 |